Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Jonathan J. Havel's publication output changed over time?
ScholarIQpublication output · 2015–2019
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2019.
1
1
1
201520172019
What are the most-cited papers on Jonathan J. Havel?
ScholarIQmost cited works
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J. Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa Ho, Martin L. Miller, Natasha Rekhtman, André L. Moreira, Fawzia K. Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B. Garon, Taha Merghoub, Jedd D. Wolchok, Ton N. Schumacher, Timothy A. Chan
Science. 20157,986 Citations
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, Walter J. Urba, Jennifer S. Sims, F. Stephen Hodi, Salvador Martín‐Algarra, Rajarsi Mandal, William H. Sharfman, Shailender Bhatia, Wen-Jen Hwu, Thomas F. Gajewski, Craig L. Slingluff, Diego Chowell, Sviatoslav M. Kendall, Han Chang, Rachna Shah, Fengshen Kuo, Luc G.T. Morris, John-William Sidhom, Jonathan P. Schneck, Christine E. Horak, Nils Weinhold, Timothy A. Chan
Cell. 20172,584 CitationsOPEN ACCESS
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel, Diego Chowell, Timothy A. Chan
Nature reviews. Cancer. 20192,359 CitationsOPEN ACCESS
Related on ScholarIQ
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Paper
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Paper
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Paper
Immune Cell Function and Interaction
Topic
T-cell and B-cell Immunology
Topic
Immunotherapy and Immune Responses
Topic